Trabajos de Luis De La Cruz-Merino

Trabajos de Nombre

Clinical Medicine

Listando 41 trabajos del autor/autora 38

Lista de trabajos en el área Clinical Medicine

Mentions 78 Twitter 0 Wikipedia 26 News 3 Policy

Article Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; de la Cruz-Merino, Luis; Beck, J. Tha JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2018.78.9909

Mentions 80 Twitter 0 Wikipedia 10 News 2 Policy

Article Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; de la Cruz-Merino, Luis; Beck, J. Thad NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2020) DOI / 10.1056/nejmoa1911149 Bronze

Mentions 62 Twitter 0 Wikipedia 9 News 0 Policy

Article Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial Ascierto, Paolo A.; Del Vecchio, Michele; Mandala, Mario; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, C. Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez-Rodas, Ivan; Butler, Marcus O.; Maio, Michele; Middleton, Mark LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(20)30494-0

Mentions 52 Twitter 0 Wikipedia 5 News 1 Policy

Article nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial Yardley, D. A.; Coleman, R.; Conte, P.; Cortes, J.; Brufsky, A.; Shtivelband, M.; Young, R.; Bengala, C.; Ali, H.; Eakel, J.; Schneeweiss, A.; de la Cruz-Merino, L.; Wilks, S.; O'shaughnessy, J.; Gluck, S.; Li, H.; Miller, J.; Barton, D.; Harbeck, N. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy201 Green published, Gold other

Mentions 77 Twitter 0 Wikipedia 0 News 0 Policy

Article SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019) Majem, M.; Garcia-Martinez, E.; Martinez, M.; Munoz-Couselo, E.; Rodriguez-Abreu, D.; Alvarez, R.; Arance, A.; Berrocal, A.; de la Cruz-Merino, L.; Lopez-Martin, J. A. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-019-02273-x Gold other

Mentions 47 Twitter 0 Wikipedia 0 News 0 Policy

Article SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer Pascual, Tomas; Cejalvo, Juan M.; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begona; de la Cruz-Merino, Luis; Juan, Manel; Ferrero-Cafiero, Juan M.; Canes, Jordi; Gonzal FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0246

Mentions 48 Twitter 0 Wikipedia 0 News 0 Policy

Article Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden Morrison, Carl; Pabla, Sarabjot; Conroy, Jeffrey M.; Nesline, Mary K.; Glenn, Sean T.; Dressman, Devin; Papanicolau-Sengos, Antonios; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Qin, Moachun; Wang, Yirong; Lenzo, Felicia L.; Omilian, Angela; Bshara, JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018) DOI / 10.1186/s40425-018-0344-8 Gold DOAJ, Green published

Mentions 5 Twitter 0 Wikipedia 2 News 0 Policy

Article SEOM clinical guidelines in advanced and recurrent breast cancer (2018) Chacon Lopez-Muniz, J. I.; de la Cruz-Merino, L.; Gavila Gregori, J.; Martinez Duenas, E.; Oliveira, M.; Segui Palmer, M. A.; Alvarez Lopez, I.; Antolin Novoa, S.; Bellet Ezquerra, M.; Lopez-Tarruella Cobo, S. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2019) DOI / 10.1007/s12094-018-02010-w Green published, Hybrid

Mentions 27 Twitter 0 Wikipedia 1 News 0 Policy

Article Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402) Maria Piulats, Jose; Espinosa, Enrique; de la Cruz-Merino, Luis; Varela, Mar; Alonso Carrion, Lorenzo; Martin-Algarra, Salvador; Lopez Castro, Rafael; Curiel, Teresa; Rodriguez-Abreu, Delvys; Redrado, Miriam; Goma, Montserrat; Jose Rullan, Antonio; Calvo G JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2021) DOI / 10.1200/jco.20.00550

Mentions 19 Twitter 0 Wikipedia 1 News 0 Policy

Article Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group Mendez, Miriam; Torrente, Maria; Sanchez-Beato, Margarita; Gonzalez-Rincon, Julia; Royuela, Ana; Gomez-Codina, Jose; de la Cruz-Merino, Luis; Rueda, Antonio; Llanos, Marta; Quero, Cristina; Rodriguez-Abreu, Delvys; Guma, Josep; Monsalvo, Silvia; Sabin, Pil HEMATOLOGICAL ONCOLOGY 0278-0232 (2019) DOI / 10.1002/hon.2601

Mentions 28 Twitter 0 Wikipedia 0 News 1 Policy

Article Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry Provencio, Mariano; Sabin, Pilar; Gomez-Codina, Jose; Torrente, Maria; Calvo, Virginia; Llanos, Marta; Guma, Josep; Quero, Cristina; Blasco, Ana; Angel Cruz, Miguel; Aguiar, David; Garcia-Arroyo, Francisco; Lavernia, Javier; Martinez, Natividad; Morales, M PLOS ONE 1932-6203 (2017) DOI / 10.1371/journal.pone.0177204 Gold DOAJ, Green published

Mentions 19 Twitter 0 Wikipedia 0 News 0 Policy

Review The tumour microenvironment as an integrated framework to understand cancer biology Burgos-Panadero, Rebeca; Lucantoni, Federico; Gamero-Sandemetrio, Esther; de la Cruz-Merino, Luis; Alvaro, Tomas; Noguera, Rosa CANCER LETTERS 0304-3835 (2019) DOI / 10.1016/j.canlet.2019.07.010 Gold other

Mentions 15 Twitter 0 Wikipedia 0 News 1 Policy

Article Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) Bachelot, T.; Ciruelos, E.; Schneeweiss, A.; Puglisi, F.; Peretz-Yablonski, T.; Bondarenko, I.; Paluch-Shimon, S.; Wardley, A.; Merot, J. -l.; du Toit, Y.; Easton, V.; Lindegger, N.; Miles, D.; Bouzid, Kamel; Campone, Mario; Coudert, Bruno; Nowecki, Zbigni ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz061 Bronze

Mentions 17 Twitter 0 Wikipedia 0 News 0 Policy

Article Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q" Gonzalez Mancha, Rosario; Munoz, Montserrat; de la Cruz-Merino, Luis; Calvo, Lourdes; Cruz, Josefina; Manuel Baena-Canada, Jose; Fernandez, Yolanda; Ramos, Manuel; Augusto Rodriguez, Cesar; Ignacio Chacon, Jose; Palomero, Isabel; Llinares, Julia; Rivero, M HEALTH AND QUALITY OF LIFE OUTCOMES (2019) DOI / 10.1186/s12955-019-1197-7 Gold DOAJ, Green published

Mentions 5 Twitter 0 Wikipedia 1 News 0 Policy

Article Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Slamon, D. J.; Neven, P.; Chia, S.; Jerusalem, G.; De Laurentiis, M.; Im, S.; Petrakova, K.; Bianchi, G. Valeria; Martin, M.; Nusch, A.; Sonke, G. S.; De la Cruz-Merino, L.; Beck, J. T.; Ji, Y.; Wang, C.; Deore, U.; Chakravartty, A.; Zarate, J. P.; Taran, ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.05.353 Hybrid

Mentions 16 Twitter 0 Wikipedia 0 News 0 Policy

Article Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors Conroy, Jeffrey M.; Pabla, Sarabjot; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Wang, Yirong; Lenzo, Felicia L.; Bshara, Wiam; Khalil, Maya; Dy, Grace K.; Madden, Katherine G.; Shirai, JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019) DOI / 10.1186/s40425-018-0489-5 Gold DOAJ, Green published

Mentions 11 Twitter 0 Wikipedia 0 News 0 Policy

Article Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma Gonzalez-Rincon, Julia; Mendez, Miriam; Gomez, Sagrario; Garcia, Juan F.; Martin, Paloma; Bellas, Carmen; Pedrosa, Lucia; Rodriguez-Pinilla, Socorro M.; Camacho, Francisca I.; Quero, Cristina; Perez-Callejo, David; Rueda, Antonio; Llanos, Marta; Gomez-Codi PLOS ONE 1932-6203 (2019) DOI / 10.1371/journal.pone.0212813 Gold DOAJ, Green published

Mentions 12 Twitter 0 Wikipedia 0 News 0 Policy

Article Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice Perez-Ruiz, E.; Jimenez-Castro, J.; Berciano-Guerrero, M-A; Valdivia, J.; Estalella-Mendoza, S.; Toscano, F.; de la Borbolla Artacho, M. Rodriguez; Garrido-Siles, M.; Martinez-Bautista, M. J.; Villatoro Roldan, R.; Rivas-Ruiz, F.; Nogales-Fernandez, E.; Mo CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02315-9

Mentions 16 Twitter 0 Wikipedia 0 News 0 Policy

Article Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial Gonzalez-Cao, Maria; Mayo Casas, Clara; Oramas, Juana; Berciano-Guerrero, Miguel A.; de la Cruz, Luis; Cerezuela, Pablo; Arance, Ana; Munoz-Couselo, Eva; Espinosa, Enrique; Puertolas, Teresa; Diaz Beveridge, Roberto; Ochenduszko, Sebastian; Villanueva, Mar NATURE COMMUNICATIONS (2021) DOI / 10.1038/s41467-021-26572-6 Gold

Mentions 17 Twitter 0 Wikipedia 0 News 0 Policy

Article Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial Jimenez-Cortegana, Carlos; Palazon-Carrion, Natalia; Garcia-Sancho, Alejandro Martin; Nogales-Fernandez, Esteban; Carnicero-Gonzalez, Fernando; Rios-Herranz, Eduardo; de la Cruz-Vicente, Fatima; Rodriguez-Garcia, Guillermo; Fernandez-Alvarez, Ruben; Doming JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021) DOI / 10.1136/jitc-2020-002323 Gold

Mentions 6 Twitter 0 Wikipedia 0 News 0 Policy

Review Integrating the Tumor Microenvironment into Cancer Therapy Sanegre, Sabina; Lucantoni, Federico; Burgos-Panadero, Rebeca; de la Cruz-Merino, Luis; Noguera, Rosa; Alvaro Naranjo, Tomas CANCERS (2020) DOI / 10.3390/cancers12061677 Gold DOAJ, Green published

Mentions 10 Twitter 0 Wikipedia 0 News 0 Policy

Review New horizons in breast cancer: the promise of immunotherapy de la Cruz-Merino, L.; Palazon-Carrion, N.; Henao-Carrasco, F.; Nogales-Fernandez, E.; Alamo-de la Gala, M.; Vallejo-Benitez, A.; Chiesa, M.; Sanchez-Margalet, V. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2019) DOI / 10.1007/s12094-018-1907-3 Gold other

Mentions 18 Twitter 0 Wikipedia 0 News 0 Policy

Article 5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF(V600) Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study Ascierto, Paolo A.; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Atkinson, Victoria; Dutriaux, Caroline; Garbe, Claus; Hsu, Jess CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-0809

Mentions 7 Twitter 0 Wikipedia 0 News 0 Policy

Review 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary Losa, F.; Iglesias, L.; Pane, M.; Sanz, J.; Nieto, B.; Fuste, V.; de la Cruz-Merino, L.; Concha, A.; Balana, C.; Matias-Guiu, X. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-018-1899-z Green published, Gold other

Mentions 1 Twitter 0 Wikipedia 0 News 1 Policy

Article Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF(V600) mutation-positive melanoma Dreno, Brigitte; Ascierto, Paolo A.; Atkinson, Victoria; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Dutriaux, Caroline; Garbe, Claus; Bartley, Karen; Karagiannis, Thomas; Ch BRITISH JOURNAL OF CANCER 0007-0920 (2018) DOI / 10.1038/bjc.2017.488 Green published, Gold other

Mentions 7 Twitter 0 Wikipedia 0 News 0 Policy

Article SEOM clinical guideline for the management of cutaneous melanoma (2020) Majem, M.; Manzano, J. L.; Marquez-Rodas, I.; Mujika, K.; Munoz-Couselo, E.; Perez-Ruiz, E.; de la Cruz-Merino, L.; Espinosa, E.; Gonzalez-Cao, M.; Berrocal, A. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2021) DOI / 10.1007/s12094-020-02539-9 Gold other

Mentions 7 Twitter 0 Wikipedia 0 News 0 Policy

Article Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma Halwani, Ahmad S.; Panizo, Carlos; Isufi, Iris; Herrera, Alex F.; Okada, Craig Y.; Cull, Elizabeth H.; Kis, Bela; Chaves, Jorge M.; Bartlett, Nancy L.; Ai, Weiyun; de la Cruz-Merino, Luis; Bryan, Locke J.; Houot, Roch; Linton, Kim; Briones, Javier; Chau, I LEUKEMIA & LYMPHOMA 1042-8194 (2021) DOI / 10.1080/10428194.2021.2010057

Mentions 4 Twitter 0 Wikipedia 0 News 0 Policy

Article Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival Mandala, Mario; Larkin, James; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cowey, C. Lance; Arance, Ana; Dalle, Stephane; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez, Ivan; Butler, Marcus O.; Di Giacomo, Anna Mar JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021) DOI / 10.1136/jitc-2021-003188 Green published, Gold

Mentions 2 Twitter 0 Wikipedia 0 News 0 Policy

Article Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma Garcia-Carbonero, Rocio; Marquez-Rodas, Ivan; de la Cruz-Merino, Luis; Martinez-Trufero, Javier; Angel Cabrera, Miguel; Maria Piulats, Jose; Capdevila, Jaume; Grande, Enrique; Martin-Algarra, Salvador; Berrocal, Alfonso ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2018-0718 Green published, Bronze

Mentions 4 Twitter 0 Wikipedia 0 News 0 Policy

Article Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study de la Cruz-Merino, Luis; Gion, Maria; Cruz-Jurado, Josefina; Quiroga, Vanesa; Andres, Raquel; Moreno, Fernando; Alonso-Romero, Jose L.; Ramos, Manuel; Holgado, Esther; Cortes, Javier; Lopez-Miranda, Elena; Henao-Carrasco, Fernando; Palazon-Carrion, Natalia CANCERS (2021) DOI / 10.3390/cancers13215432 Gold